DWTX Dogwood Therapeutics, Inc.
Healthcare$1.78-0.56%ClosedMarket Cap: $3.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.74
P/S
0.00
EV/EBITDA
0.34
DCF Value
$0.69
FCF Yield
-453.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-35.9%
ROA
-29.7%
ROIC
-30.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-5.1M | $-5.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.8M | $-3.8M | $— | — |
| FY null | $0.00 | NaN% | $-28.0M | $-34.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.8M | $-15.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.9M | $-3.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.4M | $-10.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.5M | $-7.7M | $— | — |
| FY null | $0.00 | NaN% | $-12.2M | $-12.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.1M | $-1.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.3M | $-1.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.1M | $-1.1M | $-1.43 | — |